NDC 76466-010 Vagi-cure (maximum Strength)

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
76466-010
Proprietary Name:
Vagi-cure (maximum Strength)
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Sci International, Inc. Dba Continental Pharmaceuticals
Labeler Code:
76466
Start Marketing Date: [9]
01-01-2011
Listing Expiration Date: [11]
12-31-2019
Exclude Flag: [12]
I
Code Structure:
Code Navigator:

Product Packages

NDC Code 76466-010-07

Package Description: 28 g in 1 TUBE

Product Details

What is NDC 76466-010?

The NDC code 76466-010 is assigned by the FDA to the product Vagi-cure (maximum Strength) which is product labeled by Sci International, Inc. Dba Continental Pharmaceuticals. The product's dosage form is . The product is distributed in a single package with assigned NDC code 76466-010-07 28 g in 1 tube . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Vagi-cure (maximum Strength)?

Apply a fingertip amount adults and children (approximately 1-inch strip) 12 years and older to affected area not more than 3 to 4 times daily children under 12 years consult a doctor

Which are Vagi-cure (maximum Strength) UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Vagi-cure (maximum Strength) Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Vagi-cure (maximum Strength)?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 637518 - benzocaine 20 % / resorcinol 3 % Vaginal Cream
  • RxCUI: 637518 - benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".